Search results for "PROGNOSIS"

showing 10 items of 2052 documents

Malondialdehyde in early phase of acute pancreatitis

2011

Aims: to assess oxidative stress in acute pancreatitis, its evolution over time and its relationship with the severity of the disease. Methods: during a two-year period, patients with acute pancreatitis with less than 24 hours of pain were evaluated. Serum was obtained the first, second and fourth day from admittance, if complications were detected, and after recovery. Malondialdehyde was determined by high performance liquid chromatography. Twenty healthy volunteers constituted the control group. Malondialdehyde between groups was compared with Mann-Whitney and Kruskal-Wallis tests; malondialdehyde evolution was studied with Wilcoxon test. Results: one hundred and sixty-nine patients were …

AdultMaleComplicationsmedicine.disease_causeSeverity of Illness Indexchemistry.chemical_compoundMalondialdehydeHealthy volunteersHumansMedicineProspective StudiesChromatography High Pressure LiquidAgedAged 80 and overbusiness.industryGastroenterologyGeneral MedicineMiddle AgedPrognosismedicine.diseaseMalondialdehydeAcute pancreatitisOxidative StressPancreatitischemistryOxidative stressCase-Control StudiesAnesthesiaAcute DiseaseDisease ProgressionAcute pancreatitisPancreatitisFemalebusinessEarly phaseBiomarkersOxidative stressRevista Española de Enfermedades Digestivas
researchProduct

Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive …

2018

Intrahepatic cholangiocarcinoma (ICC) is a rare malignancy, and therefore large unicenter series on the surgical outcome are rare in the literature, and prognostic factors for overall survival in the literature vary widely.All patients who underwent surgery for ICC were prospectively recorded. The type of resection, operative details, histological results, morbidity, mortality, overall and recurrence-free survivals as well as prognostic factors were assessed. Prognostic factors were examined by univariate and multivariate analyses. P-values0.05 were considered significant.Between January 2008 and December 2015, 102 patients underwent a resection with curative intent and were included in thi…

AdultMaleCurative resectionmedicine.medical_specialtyMultivariate analysis030230 surgeryMalignancySingle CenterDisease-Free SurvivalCholangiocarcinoma03 medical and health sciences0302 clinical medicinemedicineHepatectomyHumansNeoplasm InvasivenessIntrahepatic CholangiocarcinomaAgedRetrospective StudiesAged 80 and overAnalysis of VarianceUnivariate analysisbusiness.industryRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurgeryVisceraBile Ducts IntrahepaticTreatment OutcomeBile Duct Neoplasms030220 oncology & carcinogenesisFemaleSurgerybusinessInfiltration (medical)International Journal of Surgery
researchProduct

High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression

2013

Tryptase(+) mast cells (MCs), abundant in the invasive front of tumours, contribute to tissue remodelling. Indeed, protease-activated receptor- 2 (PAR-2) activation by MC-tryptase is considered an oncogenic event in colorectal cancer (CRC). Recently, we have suggested NHERF1 as a potential new marker in CRC. In this study, we aimed to determine the distribution of tryptase(+) MCs and PAR-2 and to examine the relationship between PAR-2 and NHERF1, investigating their reputed usefulness as tumour markers. We studied a cohort of 115 CRC specimens including primary cancer (C) and adjacent normal mucosa (NM) by immunohistochemical double staining, analyzing the protein expression of MC-tryptase,…

AdultMaleCytoplasmPathologymedicine.medical_specialtySodium-Hydrogen ExchangersColorectal cancerLymphovascular invasionSettore MED/06 - Oncologia MedicainvasivenesstryptasePAR-2Cell CountTryptaseModels BiologicalImmunophenotypingNHERF1Intestinal mucosamedicineHumansReceptor PAR-2Mast CellsIntestinal Mucosaprognostic factorProtease-activated receptor 2AgedAged 80 and overbiologyColorectal cancer PAR-2 mast cell tryptase NHERF1 prognostic factor invasiveness aggressivenessOriginal ArticlesCell BiologyaggressivenessMiddle AgedPhosphoproteinsPrognosismedicine.diseaseMast cellColorectal cancermedicine.anatomical_structurebiology.proteinMolecular MedicineImmunohistochemistryFemaleTryptasesmast cellColorectal Neoplasms
researchProduct

Supportive periodontal therapy and periodontal biotype as prognostic factors in implants placed in patients with a history of periodontitis

2013

Objectives: To evaluate bone loss around implants placed in patients with a history of treated chronic periodontitis and who did or did not attend supportive periodontal therapy, after one year in function. Furthermore, the influence of periodontal biotype and level of plaque was also evaluated. Material and Methods: Forty-nine patients participated voluntarily in the study. All subjects had a history of chronic periodontitis, which had been previously treated. After the active treatment, 27 patients attended supportive periodontal therapy (SPT) and the rest did not (No SPT). The O’Leary plaque index and periodontal biotype were recorded for each subject and 246 Astra Tech® OsseospeedTM imp…

AdultMaleDentistryOdontologíamedicineMucositisHumansPeriodontologyRisk factorGeneral DentistrySurvival rateAgedPeriodontitisOrthodonticsbusiness.industryDental prosthesisDental Plaque IndexMiddle Agedmedicine.diseasePrognosis:CIENCIAS MÉDICAS [UNESCO]Chronic periodontitisCiencias de la saludDental Plaque IndexOtorhinolaryngologyChronic PeriodontitisUNESCO::CIENCIAS MÉDICASSurgeryResearch-ArticleFemaleImplantDental Prosthesis Implant-Supportedbusiness
researchProduct

Bcl-2 as prognostic factor in head and neck squamous cell carcinoma

2005

A series of 66 cases of oral squamous cell carcinoma (OSCC) was retrospectively analyzed by immunohisto-chemistry for bcl-2 expression to verify its predictive value for clinical outcome in patients with OSCC. After grouping for bcl-2 expression, OSCCs were statistically analyzed for the variables age, gender, histological grading (G), TNM, staging, recurrence, and overall survival rate. Univariate and multivariate (Cox regression) analyses were performed. Thirty-six OSCC (54.5%) showed expression for bcl-2, whereas 30 (44.5%) were negative. No statistical association was found between bcl-2 expression and any variables considered at baseline. Overall disease-specific survival rate at 72 mo…

AdultMaleEXPRESSIONOncologyCancer Researchmedicine.medical_specialtyPathologyAdolescentSPONTANEOUS APOPTOSISPROTEINBCL-2Internal medicinemedicineCarcinomaHumansPROGNOSTIC SIGNIFICANCEGrading (tumors)Survival rateIMMUNOHISTOCHEMICAL ANALYSISORAL-CAVITYIN-VIVOAgedRetrospective StudiesAged 80 and overProportional hazards modelbusiness.industryCancerRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseImmunohistochemistryCANCERHead and neck squamous-cell carcinomaSurvival RateFAMILY-MEMBERSstomatognathic diseasesProto-Oncogene Proteins c-bcl-2OncologySQUAMOUS CELL CARCINOMAHead and Neck NeoplasmsBAXCarcinoma Squamous CellRegression AnalysisImmunohistochemistryFemalebusinessONCOPROTEIN
researchProduct

Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival

2018

OBJECTIVESpinal ependymomas are rare glial neoplasms. Because their incidence is low, only a few larger studies have investigated this condition. There are no clear data concerning prognosis and therapy. The aim of the study was to describe the natural history, perioperative clinical course, and local tumor control of adult patients with spinal ependymomas who were surgically treated under modern treatment standards.METHODSThe authors performed a multicenter retrospective study. They identified 158 adult patients with spinal ependymomas who had received surgical treatment between January 2006 and June 2013. The authors analyzed the clinical and histological aspects of these cases to identif…

AdultMaleEpendymomaMicrosurgerymedicine.medical_specialtyAdolescentSpinal intradural tumormedicine.medical_treatmentYoung Adult03 medical and health sciences0302 clinical medicineRecurrenceNeoplasmsBiomarkers TumormedicineHumansSpinal Cord NeoplasmsProgression-free survivalGrading (tumors)AgedRetrospective StudiesAged 80 and overSpinal cordbusiness.industryIncidence (epidemiology)Retrospective cohort studyGeneral MedicinePerioperativeMiddle AgedPrognosismedicine.diseaseProgression-Free Survivalddc:616.8SurgeryRadiation therapyKi-67 AntigenLocalOncologyEpendymomaTumor progression030220 oncology & carcinogenesisFemaleRadiotherapy AdjuvantNeoplasm Recurrence Localbusiness030217 neurology & neurosurgeryFollow-Up StudiesJournal of Neurosurgery: Spine
researchProduct

Automatic fuzzy classification of the washout curves from magnetic resonance first-pass perfusion imaging after myocardial infarction.

2005

International audience; Abstract: Objectives: We sought to investigate the diagnostic ability of cardiac magnetic resonance imaging (MRI) perfusion in acute reper-fused myocardial infarction. The study used fuzzy logic to automatically classify signal intensity-time curves from myocardial segments into 3 categories: normal, hypointense, and Hyperintense. Materials and Methods: Thirty-eight patients with myocardial infarction underwent short-axis cine-MRI and contrast-enhanced MRI to provide data on wall thickening and the transmural extent of infarction. Of these, 17 had a second cardiac MRI to ascertain the functional recovery in each segment. Results: The fuzzy logic based classification …

AdultMaleFuzzy classificationfunctional recoveryMyocardial InfarctionContrast MediaMagnetic Resonance Imaging CineMyocardial Reperfusion030204 cardiovascular system & hematologyFuzzy logicStatistics Nonparametric030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFuzzy Logicdelayed imagingCardiac magnetic resonance imagingPredictive Value of Tests[INFO.INFO-IM]Computer Science [cs]/Medical ImagingmedicineImage Processing Computer-Assistedmagnetic resonance imagingHumansRadiology Nuclear Medicine and imagingMyocardial infarctionProspective StudiesAgedAged 80 and over[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingmedicine.diagnostic_testbusiness.industrycontrast-enhanced first-passWashoutMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseasePrognosisFirst pass perfusionFemaleNuclear medicinebusinessPerfusionInvestigative radiology
researchProduct

Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients.

2012

Background Here, we assessed the presence of intrahepatic follicular helper T-cells (TFH) in a cohort of consecutive genotype 1 (G1) chronic hepatitis C (CHC) patients comprising non-responders (NRs), relapsers (RRs) or those with sustained virological response (SVR) to pegylated interferon and ribavirin, and tested their relation with the response to antiviral treatment. Methods A total of 78 patients with G1 CHC (30 SVR, 15 RR and 33 NR), comparable for sex, age, viral load and fibrosis were evaluated by immunohistochemistry for liver content of PD1+Bcl6+ TFH cells. The number of TFH cells in the immunostained sections was counted out of five representative high-power microscopic fields (…

AdultMaleGenotypeHepacivirusSettore MED/08 - Anatomia PatologicaAntiviral AgentsPolymorphism Single NucleotideBiomarkers PharmacologicalPolyethylene GlycolsCohort StudiesPharmacotherapyInterferonRibavirinGenotypeFollicular phaseHumansMedicinePharmacology (medical)liver biopsy Interferon-alpha follicular helper T-cellsPharmacologySettore MED/12 - Gastroenterologiabusiness.industryInterleukinsInterferon-alphaT-Lymphocytes Helper-InducerHepatitis CHepatitis C ChronicMiddle AgedViral LoadPrognosismedicine.diseaseImmunohistochemistryRecombinant ProteinsCD4 Lymphocyte CountInfectious DiseasesLiverImmunologyCohortRNA ViralImmunohistochemistryDrug Therapy CombinationFemalehcv immunohistochemistryInterferonsbusinessCohort studymedicine.drug
researchProduct

Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-α therapy

1998

Abstract Background/Aims: So far, there are no reliable parameters that can predict the long-term sustained response to treatment with interferon-α in patients with chronic hepatitis C. In this study, we have developed a semi-quantitative method to determine the viral load per liver cell and have correlated this factor with the outcome of hepatitis C patients treated with interferon-α. Methods: Hepatitis C virus RNA levels were measured in serum, peripheral blood mononuclear cells and liver cells of randomly chosen hepatitis C patients before treatment with interferon-α ( n =37). The number of cells present in the liver biopsies was determined by a polymerase chain reaction-based quantitati…

AdultMaleGenotypeHepatitis C virusmedicine.medical_treatmentHepacivirusmedicine.disease_causePeripheral blood mononuclear cellPredictive Value of TestsHumansMedicineSerotypingInterferon alfaAgedHepatitis ChronicHepatologybusiness.industryLiver cellAge FactorsInterferon-alphaHepatitis CMiddle AgedViral LoadPrognosismedicine.diseaseHepatitis CTreatment OutcomeCytokineLiverImmunologyLeukocytes MononuclearRNA ViralFemaleViral diseasebusinessViral loadmedicine.drugJournal of Hepatology
researchProduct

Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time

2015

Abstract Background The proportion of cases notified by death certificate only (DCO) is a commonly used data quality indicator in studies comparing cancer survival across regions and over time. We aimed to assess dependence of DCO proportions on the age structure of cancer patients. Methods Using data from a national cancer survival study in Germany, we determined age specific and overall (crude) DCO proportions for 24 common forms of cancer. We then derived overall (crude) DCO proportions expected in case of shifts of the age distribution of the cancer populations by 5 and 10 years, respectively, assuming age specific DCO proportions to remain constant. Results Median DCO proportions acros…

AdultMaleGerontologyCancer ResearchTime FactorsAdolescentAge structureAge adjustmentRisk AssessmentDeath CertificatesYoung Adult03 medical and health sciencesAge Distribution0302 clinical medicineAge groupsRisk FactorsGermanyNeoplasmsmedicineHumansRegistries030212 general & internal medicineAgedRelative survivalbusiness.industryAge FactorsCancerCancer survivalMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurvival RateOncology030220 oncology & carcinogenesisDeath Certificate OnlyFemaleAge distributionbusinessDemographyEuropean Journal of Cancer
researchProduct